Drug · DIN 02293269
CAMPRAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 28, 2010; first marketed July 30, 2007.
- Drug Identification Number (DIN)
- 02293269
- Company (DIN owner)
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Delayed-Release)
- Route
- Oral
- Therapeutic class (ATC)
- Acamprosate N07BB03
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ACAMPROSATE CALCIUM | 333 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- June 29, 2009: NOC 10316New Drug Submission (NDS) · Manufacturer name change
- March 16, 2007: NOC 8652New Drug Submission (NDS)